AwardedCzechiaGoodsFramework agreementCZK 518,000
Dodávky léčivých přípravků s účinnou látkou RILPIVIRIN
- Published
- Published 26 March 2026
- Deadline
- Closed 27 April 2026
Overview
Krajská zdravotní, a.s. procured continuous supplies of medicinal preparations containing the active substance RILPIVIRIN for use as a healthcare provider through a 24-month framework agreement. GlaxoSmithKline, s.r.o. was awarded the contract on 8 June 2026 for 517,982.4 CZK, including direct delivery to pharmacies at the buyer's affiliated facilities.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 518,000
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 26 March 2026
- Deadline
- Closed
Antivirals for systemic use
Award outcome
- Awarded value
- CZK 517,982
- Award date
- 8 June 2026
- Contract period
- 19 June 2026 → 8 June 2028
- GlaxoSmithKline, s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
25 June 2026
Contract Notice
26 March 2026
Contracting authority
Krajská zdravotní, a.s.
Procuring entityÚstí nad Labem, Czechia
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.